PTPI insider filings
Petros Pharmaceuticals, Inc. — 35 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-08. Screen PTPI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for PTPI between 2026-07-26 and 2026-10-24. The table below lists the most recent filings on record.
Recent insider filings — Petros Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | WALKER WAYNE REMELL — Director | Grant/award (A): 375,000 @ $0 | EDGAR |
| 2026-06-05 | 4 | Boctor Fady — See Remarks | Grant/award (A): 375,000 @ $0 | EDGAR |
| 2026-06-05 | 4 | Bernstein Bruce — Director | Grant/award (A): 1,875,000 @ $0 | EDGAR |
| 2026-06-05 | 4 | Silverman Joshua — Director | Grant/award (A): 4,375,000 @ $0 | EDGAR |
| 2026-01-06 | 4 | Boctor Fady — See Remarks | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2026-01-02 | 4 | Bernstein Bruce — Director | Grant/award (A): 1,875,000 @ $0 | EDGAR |
| 2026-01-02 | 4 | Silverman Joshua — Director | Grant/award (A): 4,375,000 @ $0 | EDGAR |
| 2026-01-02 | 4 | WALKER WAYNE REMELL — Director | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Arnold Mitchell — See Remarks | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Boctor Fady — See Remarks | Grant/award (A): 450,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Bernstein Bruce — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Silverman Joshua — Director | Grant/award (A): 1,000,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | WALKER WAYNE REMELL — Director | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2023-12-26 | 4 | Boctor Fady — See Remarks | Grant/award (A): 49,645 @ $0 · Grant/award (A): 54,533 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | Arnold Mitchell — See Remarks | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | Bradley Greg — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | Bernstein Bruce — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | Silverman Joshua — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | WALKER WAYNE REMELL — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-04-28 | 4 | Bradley Greg — Director | Option exercise (M): 6,050 · Option exercise (M): 6,050 (derivative) @ $0 | EDGAR |
| 2023-04-28 | 4 | Bernstein Bruce — Director | Option exercise (M): 6,050 · Option exercise (M): 6,050 (derivative) @ $0 | EDGAR |
| 2023-04-28 | 4 | Silverman Joshua — Director | Option exercise (M): 6,722 · Option exercise (M): 6,722 (derivative) @ $0 | EDGAR |
| 2023-04-28 | 4 | WALKER WAYNE REMELL — Director | Option exercise (M): 6,050 · Option exercise (M): 6,050 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | Bradley Greg — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | Bernstein Bruce — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | Silverman Joshua — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | WALKER WAYNE REMELL — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Bradley Greg — Director | Option exercise (M): 2,264 · Option exercise (M): 2,264 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Bernstein Bruce — Director | Option exercise (M): 2,264 · Option exercise (M): 2,264 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Silverman Joshua — Director | Option exercise (M): 2,515 · Option exercise (M): 2,515 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | WALKER WAYNE REMELL — Director | Option exercise (M): 2,264 · Option exercise (M): 2,264 (derivative) @ $0 | EDGAR |
| 2022-04-11 | 4 | Bradley Greg — Director | Grant/award (A): 60,505 (derivative) @ $0 | EDGAR |
| 2022-04-11 | 4 | Bernstein Bruce — Director | Grant/award (A): 60,505 (derivative) @ $0 | EDGAR |
| 2022-04-11 | 4 | Silverman Joshua — Director | Grant/award (A): 67,227 (derivative) @ $0 | EDGAR |
| 2022-04-11 | 4 | WALKER WAYNE REMELL — Director | Grant/award (A): 60,505 (derivative) @ $0 | EDGAR |
Recent 8-K events — Petros Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-30 | 8-K | 1.03 — Bankruptcy or Receivership 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-07 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-09-05 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-21 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-05-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-11 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PTPI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs